Compare · AONC vs HIMS
AONC vs HIMS
Side-by-side comparison of American Oncology Network Inc. (AONC) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AONC and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS carries a market cap of $4.00B.
- HIMS has hit the wire 28 times in the past 4 weeks while AONC has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 0 for AONC).
- Company
- American Oncology Network Inc.
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- -
- $4.00B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2019
- News (4w)
- 0
- 28
- Recent ratings
- 0
- 25
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest AONC
- Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology
- SEC Form 10-K filed by American Oncology Network Inc.
- Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah
- SEC Form 15-15D filed by American Oncology Network Inc.
- Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting
- Amendment: American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation
- SEC Form EFFECT filed by American Oncology Network Inc.
- SEC Form S-8 POS filed by American Oncology Network Inc.
Latest HIMS
- Chief Legal Officer Soleil Boughton sold $64,077 worth of shares (3,458 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 311,190 units (SEC Form 4)
- Chief Policy Officer Deborah M. Autor sold $441,533 worth of shares (23,828 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 33% to 48,961 units (SEC Form 4)
- Chief Financial Officer Oluyemi Okupe sold $65,189 worth of shares (3,518 units at $18.53) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 266,188 units (SEC Form 4)
- Hims & Hers Launches Peptides+, a New Clinically-Guided Specialty for Access to Personalized, Proactive Health
- Director Christopher D Payne converted options into 810 shares, increasing direct ownership by 2% to 35,673 units (SEC Form 4)
- Chief Legal Officer Soleil Boughton converted options into 42,262 shares and covered exercise/tax liability with 21,500 shares, increasing direct ownership by 7% to 314,648 units (SEC Form 4) (tax withholding)
- CTO Mohamed Elshenawy converted options into 188,286 shares and covered exercise/tax liability with 95,798 shares, increasing direct ownership by 50% to 278,044 units (SEC Form 4) (for withholding tax)
- Chief Medical Officer Patrick Harrison Carroll converted options into 25,927 shares and covered exercise/tax liability with 10,200 shares, increasing direct ownership by 8% to 213,574 units (SEC Form 4) (for tax liability)
- Chief Policy Officer Deborah M. Autor converted options into 39,974 shares and covered exercise/tax liability with 16,146 shares, increasing direct ownership by 49% to 72,789 units (SEC Form 4) (withholding obligation)
- Chief Operating Officer Michael Chi converted options into 69,769 shares and covered exercise/tax liability with 38,581 shares, increasing direct ownership by 7% to 487,848 units (SEC Form 4) (tax withholding)